|
|
A conversation with Chris Hwang, CTO, Transcenta Holding Ltd.
At a recent Evaluating BioPharma virtual event, moderator John Bonham-Carter asked Chris Hwang, chief technology officer at Transcenta Holding Ltd., about Chris’s journey and experiences with continuous bioprocessing thus far in his career.
|